Compared with those in the control mice, both C-176 and IFNAR1 antibody treatment prevented Nap1l1 p.D349E-mediated cardiac hypertrophy and fibrosis (Fig. 5B, C). Here, NAP1L1 is linked to cardiac hypertrophy.